Navigation Links
Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
Date:1/17/2013

proval for Ampligen, the FDA noted that "[i]t would be unusual for this type of data to provide adequate evidence of efficacy."

Upon review of the post-hoc analyses, on December 18, 2012, the FDA released a report citing that the additional information submitted by the Company was insufficient. The report further stated that the Company's studies were "ill-defined and invalid," noting inconsistencies regarding the effectiveness and finding nine potential safety concerns. As a result of this news, Hemispherx shares declined $0.276 per share, or approximately 43%, closing at $.368 per share on December 18, 2012.

If you purchased or otherwise acquired Hemispherx stock during the Class Period and wish to serve as lead plaintiff, you must act no later than February 22, 2013.  To discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, inquiry@robbinsarroyo.com, or via the shareholder information form on the firm's website. 

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to http://www.robbinsarroyo.com.

Press release link: http://www.robbinsarroyo.com/shareholders-rights-blog/hemispherx-biopharma-inc/

Attorney Advertising. Past results do not guarantee a similar outcom
'/>"/>

SOURCE Robbins Arroyo LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... -- Over the next five years, the marijuana industry in the ... that 14 more states will legalize recreational marijuana and two ... legal cannabis grew 74 percent in 2014 to $2.7 billion, ... could grow more than fourfold to $11 billion in the ... marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) is a ...
(Date:4/17/2015)... 16, 2015 Research and Markets ( ... "Corporate Reputation of Pharma in 2014 - a Perspective ... to their offering. This independent study, funded ... groups with an interest in diabetes on the corporate ... pharma industry as a whole) in 2014. The results ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has announced ... in 2014 - a Perspective of Mental Health Patient ... For the first time, in 2014, the ... the pharmaceutical industry held by patient groups with an ... organisations representing all therapy areas. - Findings ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... Novo Software™, a leading provider of flow cytometry data ... cytometry instruments and reagents, announced today an agreement whereby ... FCS Express™ – to customers in clinical, research and ... FCS Express with every CyFlow® Cube instrument and resell ...
... (OTC Bulletin Board: NEPH ) announced that it ... Administration ("FDA") of the 510(k) application for marketing clearance of ... Nephros submitted a new 510(k) application to market its hemodiafiltration ... Nephros received the initial FDA review of its new 510(k) ...
Cached Medicine Technology:Partec to Distribute FCS Express 4 Flow Cytometry with CyFlow Cube™ Instruments 2Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 2Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 3Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 4
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining how ... , Clients can review important auto insurance quotes online, ... important advantages for clients who need affordable financial security ... have coverage for their vehicles can purchase a policy ... Many agencies offer important discounts and drivers can learn ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has ... "We had to run maintenance on our shipping facilities ... Ramirez, the PR Director. "It disrupted our regular shipping ... are back on track after having completed the maintenance." ... phone systems which has not allowed some calls to ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 ERGO-Pedic Products, ... is introducing two new products to help a broader ... back pain relief are the second most common visitors ... first product, designed specifically to help relieve sitting pain. ... Cushion, and thousands of happy customers later, we began ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2
... suggests it could show who will respond best to ... -- Genetic differences might explain why some multiple sclerosis ... an international study. , Starting with 206 southern European ... the disease, the researchers compared the DNA of patients ...
... enhancements in key genes connected to the p53 regulatory ... by creating additional safeguards in human genes to boost ... could cause cancer or a variety of genetic diseases, ... Hospital Medical Center writes in the Jan. 22 Proceedings ...
... a,statement by Reverend Carlton W. Veazey, President and CEO ... 35th anniversary of Roe v. Wade, our country is ... be safe, legal, and available,if and when it is ... the ,fetal personhood, initiatives and outright abortion bans,being promoted ...
... Inc, (TSX:,DAX) (NASDAQ: DRAX ) has received approval ... Normal Course Issuer Bid (NCIB) to,purchase up to 4,072,054 ... shares in the public float as at January 14, ... DRAXIS were issued and,outstanding., Purchases may begin on ...
... Ross J. Horsburgh Brings 20 Years of Pharmaceutical and CRO ... in Asia/Pacific Region to Key Leadership Role, ... a,leading, global full-service clinical research organization (CRO), today,announced Dr. Ross ... Development - Asia/Pacific. In this role, he will lead the,company,s ...
... be treated with Traditional Chinese medicine (TCM). Some say ... a research group in China had found TCM can ... suppress tumor cell growth and regulate tumor cell invasion ... 7, 2008 in the World Journal of Gastroenterology ...
Cached Medicine News:Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 3Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 4Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:DRAXIS Share Buyback Approved by TSX 2Health News:DRAXIS Share Buyback Approved by TSX 3Health News:DRAXIS Share Buyback Approved by TSX 4Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 2Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 3Health News:How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma? 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: